Cardiovascular aspects of primary hyperparathyroidism

被引:90
作者
Walker, M. D. [1 ]
Silverberg, S. J. [1 ]
机构
[1] Columbia Univ Coll Phys & Surg, Div Endocrinol, New York, NY 10032 USA
关键词
Cardiovascular; mortality; primary hyperparathyroidism;
D O I
10.1007/BF03346443
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Data concerning the cardiovascular manifestations of primary hyperparathyroidism (PHPT) are inconsistent, which is due, in part, to the decrease in disease severity over the last several decades. In areas where patients tend to be more symptomatic, data support the presence of cardiovascular findings including myocardial and vascular calcification as well as increased cardiovascular mortality. Data from the cohorts in whom the disease is characterized by mild hypercalcemia, suggest that clinically overt cardiovascular manifestations are unusual in PHPT. Recent data, however, support the presence of subtle cardiovascular manifestations in mild disease, such as changes in endothelial function as well as increased vascular stiffness and perhaps diastolic dysfunction. Left ventricular hypertrophy is a more consistent finding across a spectrum of disease severity, though this finding may be related to hypertension, which has long been associated with PHPT.
引用
收藏
页码:925 / 931
页数:7
相关论文
共 70 条
[61]   Survival after surgical treatment for primary hyperparathyroidism [J].
Söreide, JA ;
van Heerden, JA ;
Grant, CS ;
Lo, CY ;
Schleck, C ;
Ilstrup, DM .
SURGERY, 1997, 122 (06) :1117-1123
[62]   CALCIUM-DEPENDENT FLUORESCENCE TRANSIENTS DURING VENTRICULAR-FIBRILLATION [J].
STEFENELLI, T ;
WIKMANCOFFELT, J ;
WU, ST ;
PARMLEY, WW .
AMERICAN HEART JOURNAL, 1990, 120 (03) :590-597
[63]   PRIMARY HYPERPARATHYROIDISM - INCIDENCE OF CARDIAC ABNORMALITIES AND PARTIAL REVERSIBILITY AFTER SUCCESSFUL PARATHYROIDECTOMY [J].
STEFENELLI, T ;
MAYR, H ;
BERGLERKLEIN, J ;
GLOBITS, S ;
WOLOSZCZUK, W ;
NIEDERLE, B .
AMERICAN JOURNAL OF MEDICINE, 1993, 95 (02) :197-202
[64]   Cardiac abnormalities in patients with primary hyperparathyroidism: Implications for follow-up [J].
Stefenelli, T ;
Abela, C ;
Frank, H ;
KollerStrametz, J ;
Globits, S ;
BerglerKlein, J ;
Niederle, B .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (01) :106-112
[65]  
STEFENELLI T, 1993, WIEN KLIN WOCHENSCHR, V105, P339
[66]  
Surawicz B, 1966, Prog Cardiovasc Dis, V8, P364, DOI 10.1016/S0033-0620(66)80011-7
[67]   HYPERTENSIVE EFFECTS OF CALCIUM INFUSION IN SUBJECTS WITH NORMOTENSION AND HYPERTENSION [J].
SUZUKI, T ;
AOKI, K .
JOURNAL OF HYPERTENSION, 1988, 6 (12) :1003-1008
[68]  
SYMONS C, 1985, BRIT HEART J, V54, P539
[69]   Cardiovascular events before and after surgery for primary hyperparathyroidism [J].
Vestergaard, P ;
Mollerup, CL ;
Frokjær, VG ;
Christiansen, P ;
Blichert-Toft, M ;
Mosekilde, L .
WORLD JOURNAL OF SURGERY, 2003, 27 (02) :216-222
[70]   Survival after the diagnosis of hyperparathyroidism: A population-based study [J].
Wermers, RA ;
Khosla, S ;
Atkinson, EJ ;
Grant, CS ;
Hodgson, SF ;
O'Fallon, WM ;
Melton, LJ .
AMERICAN JOURNAL OF MEDICINE, 1998, 104 (02) :115-122